Arcellx, Inc. (ACLX)
NASDAQ: ACLX · Real-Time Price · USD
69.84
+2.60 (3.87%)
Feb 11, 2026, 4:00 PM EST - Market closed
Arcellx Market Cap
Arcellx has a market cap or net worth of $4.04 billion as of February 12, 2026. Its market cap has increased by 18.67% in one year.
Market Cap
4.04B
Enterprise Value
3.52B
1-Year Change
18.67%
Ranking
Category
Stock Price
$69.84
Market Cap Chart
Since the IPO on February 4, 2022, Arcellx's market cap has increased from $503.15M to $4.04B, an increase of 702.61%. That is a compound annual growth rate of 67.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 3.89B | 3.13% |
| Dec 31, 2025 | 3.77B | -9.09% |
| Dec 31, 2024 | 4.15B | 43.89% |
| Dec 29, 2023 | 2.88B | 112.13% |
| Dec 30, 2022 | 1.36B | 170.02% |
| Feb 4, 2022 | 503.15M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corcept Therapeutics | 4.31B |
| CG Oncology | 4.28B |
| TG Therapeutics | 4.26B |
| Terns Pharmaceuticals | 4.15B |
| NewAmsterdam Pharma Company | 3.96B |
| ADMA Biologics | 3.87B |
| ACADIA Pharmaceuticals | 3.84B |
| Erasca | 3.70B |